Factory-Direct Cardiovascular Risk Assessment Test Kit For Accurate Results

Specific Protein Solution
Series	Product Name	Product Name
Cardiovascular Risk Assessment	Apolipoprotein A1	ApoA1
	Apolipoprotein B	ApoB
	Lipoprotein (a)	Lp(a)
	High Sensitive C-reaction	hs-CRP

The assessment of the overall risk of cardiovascular disease (CVD) is based on the level of a variety of risk factors for cardiovascular disease and combined to judge or predict a person or a group of people in the future five years, ten years or the rest of my life with an acute cardiovascular disease events (acute myocardial infarction, sudden death of coronary heart disease and other coronary death, as well as acute cerebral apoplexy) of probability, The main emphasis is on the judgment or prediction of the future risk of ischemic cardiovascular disease based on atherosclerosis (ASCVD). Apolipoprotein is the protein part of plasma lipoprotein, which can bind and transport blood lipids to various tissues of the body for metabolism and utilization. A large number of studies have found that the mutation of apolipoprotein gene leads to the formation of different allelic polymorphisms and further formation of different phenotypes of apolipoprotein, which can affect the metabolism and utilization of blood lipids, thus affecting the occurrence and development of hyperlipidemia, atherosclerosis, cardiovascular and cerebrovascular diseases, etc. ApoA1 is the largest ApoA component and the main apolipoprotein in HDL. Low ApoA1 is common in atherosclerosis. Apolipoprotein B exists on the surface of low-density lipoprotein. Cell recognition and uptake of LDL are mainly realized by apolipoprotein B recognition. Therefore, when apolipoprotein B increases, even if LDL level is normal, it can also increase the incidence of coronary heart disease. Lipoprotein A is made primarily in the liver. Continuous elevation of lipoprotein level is closely related to angina pectoris, myocardial infarction and cerebral hemorrhage, and is an independent risk factor for stroke and coronary heart disease. Studies have shown that in elderly patients with acute cerebral infarction, patients with elevated CRP have a poor prognosis. Hs-crp content is related to the infarct size and the degree of neurological impairment, and is one of the indicators of the lesion degree of cerebral infarction patients. Moreover, CRP is also involved in the pathological process of thrombosis and arteriosclerosis, and is one of the risk factors of stroke.

Cardiovascular Risk Assessment Test Kit

Products Details

Featured Products

Contact us